Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2004
01/22/2004US20040014753 Antiinflammatory agents; enzyme inihibitor; autoimmune diseases; antiarthritic agents; central nervous system disorders
01/22/2004US20040014748 Cardiovascular disorders, central nervous susyem disorders
01/22/2004US20040014747 CRF receptor antagonists and methods relating thereto
01/22/2004US20040014737 Porphyron based neuton capture agents for cancer therapy
01/22/2004US20040014647 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them
01/22/2004DE10231105A1 Neue Diketopyrrolopyrrolpigmente New diketopyrrolopyrrole
01/22/2004DE10230490A1 Verfahren zur kontinuierlichen Herstellung von Acetylendiharnstoff Process for the continuous production of acetylene diurea
01/22/2004CA2509821A1 3-phenyl analogs of toxoflavine as kinase inhibitors
01/22/2004CA2499465A1 Biologically active compounds
01/22/2004CA2492421A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
01/22/2004CA2492022A1 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds
01/22/2004CA2491191A1 Receptor-type kinase modulators and methods of use
01/22/2004CA2489790A1 3-furanyl analogs of toxoflavine as kinase inhibitors
01/21/2004EP1382607A2 Prenyl transferase inhibitors
01/21/2004EP1382339A1 Compositions containing pyrrolo [2,3-d] pyrimidine derivatives
01/21/2004EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent
01/21/2004EP1381611A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
01/21/2004EP1381610A1 6-(2-chloro-6-fluoro-phenyl)-triazolopyrimidines
01/21/2004EP1381609A1 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides
01/21/2004EP1381608A1 Cyclohexylphenyl vasopressin agonists
01/21/2004EP1381607A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
01/21/2004EP1381606A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
01/21/2004EP1381604A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
01/21/2004EP1381370A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
01/21/2004EP1381368A2 Compositions containing imidazotriazinone for nasal application
01/21/2004CN1469879A Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines
01/21/2004CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
01/21/2004CN1469875A Pyrazole compounds useful as protein kinase inhibitors
01/21/2004CN1469874A Pyrazole compounds useful as protein kinase inhibitors
01/21/2004CN1469867A Novel phenylalanine derivatives
01/21/2004CN1135232C Piperazino derivatives as neurokinin antafonists
01/21/2004CN1135231C 1,2,4-triazolo [4,3B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them
01/20/2004US6680384 Process for preparing 4,6-diaminopyrimido[5,4-d]pyrimidines
01/20/2004US6680324 Compounds specific to adenosine A1 receptors and uses thereof
01/20/2004US6680322 Compounds specific to adenosine A1 receptors and uses thereof
01/20/2004CA2136872C Process for the manufacture of 5-dichloroacetyl-3,3,6-trimethyl-9-oxo-1,5-diazabicyclo[4.3.0]nonane
01/15/2004WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions
01/15/2004WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions
01/15/2004WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers
01/15/2004WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
01/15/2004WO2004005323A2 Affinity small molecules for the epo receptor
01/15/2004WO2004005293A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
01/15/2004WO2004005292A1 Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities
01/15/2004WO2004005291A1 Hetero-cyclicaly substituted imidazotriazines
01/15/2004WO2004005290A1 Substituted imidazotriazines
01/15/2004WO2004005289A2 Efficient synthesis of pyropheophorbide a and its derivatives
01/15/2004WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
01/15/2004WO2004005285A1 New quinuclidine amide derivatives
01/15/2004WO2004005279A2 Substituted anthranilic amide derivatives and methods of use
01/15/2004WO2004004736A1 Novel use of imidazotriazinones
01/15/2004WO2004004733A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives
01/15/2004WO2003094831A3 Novel diazabicyclic biaryl derivatives
01/15/2004WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
01/15/2004WO2003064424A3 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
01/15/2004US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders
01/15/2004US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
01/15/2004US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents
01/15/2004US20040009992 Azolylalkylazole derivatives, their preparation, and their use as pesticides
01/15/2004US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure
01/15/2004US20040009983 Azaindoles
01/15/2004US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines
01/15/2004US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles
01/15/2004US20040009933 Fluorescent nitrogenous base and nucleosides incorporating same
01/15/2004US20040009368 An anode, a hole transporting layer, a light emitting layer, and electron transporting layer and a cathode
01/15/2004CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions
01/15/2004CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions
01/15/2004CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers
01/15/2004CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives
01/15/2004CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
01/15/2004CA2492535A1 New quinuclidine amide derivatives
01/15/2004CA2491921A1 Hetero-cyclically substituted imidazotriazines
01/15/2004CA2491500A1 Substituted imidazotriazines
01/15/2004CA2491455A1 Novel use of imidazotriazinones
01/15/2004CA2489166A1 Substituted anthranilic amide derivatives and methods of use
01/15/2004CA2460051A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives
01/14/2004EP1380586A2 Photoactive benzoporphyrin derivatives
01/14/2004EP1380295A1 Photosensitiser and method for production thereof
01/14/2004EP1380293A1 Bone metabolism improving agents
01/14/2004EP1379528A1 Pyrazolopyrimidines as therapeutic agents
01/14/2004EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
01/14/2004EP1379501A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
01/14/2004EP1379250A2 A method of treating cancer
01/14/2004EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
01/14/2004EP1019385B1 Aminoaryl oxazolidinone n-oxides
01/14/2004CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
01/14/2004CN1468241A Heterocyclic compounds as ligands of the gabaa receptor
01/14/2004CN1468232A Heterocyclic sodium/proton exchange inhibitors and method
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1467034A Method for preparing piperazine and trivinyl-diamine molecular sieve catalyst
01/14/2004CN1134443C Improved method for making cross-bridged macropolycycles
01/14/2004CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate
01/14/2004CN1134441C Process for preparing sypolyphenol
01/14/2004CN1134440C 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
01/14/2004CN1134439C Pyrrolo [2,3D] pyrimidines and their use as tyrosine kinase inhibitors
01/14/2004CN1134419C Useful sypolyphenol intermediate and its preparation method
01/13/2004US6677429 Echinocandin derivatives, preparation method and application as anti-fungal agents
01/13/2004US6677368 4-aryl substituted indolinones